Explore
Porta Sophia

Press Releases

June 24, 2026 | 3rd Party Submission

William Shulman U.S. Patent Application 19/310,559 | Porta Sophia Files Third Party Submission

Patent application: DMT use and administration

View Press Release

May 22, 2026 | 3rd Party Submission

ECP Pharma U.S. Patent Application 19/283,158 | Porta Sophia Files Third Party Submission

Patent application: CBD and psilocybin combination treatment

View Press Release

May 7, 2026 | Press Release

Porta Sophia Launches PoliPsy: Free Psychedelic Policy & Clinical Trials Dashboard

PoliPsy: Real-Time Psychedelic Legislation and Clinical Trial Tracker

View Press Release

April 6, 2026 | Press Release

Virginia Psilocybin Bill SB379 Updated to Align with FDA Framework

Virginia Legislature: Updated Psilocybin Bill Aligned with FDA Regulatory Framework

View Press Release

March 11, 2026 | 3rd Party Submission

Tessellate Therapeutics Inc. U.S. Patent Application 18/860,502 | Porta Sophia Files Third Party Submission

Patent application: salts of 4-substituted tryptamines

View Press Release

December 18, 2025 | 3rd Party Submission

Enveric Biosciences Canada Inc. U.S. Patent Application 18/848,367 | Porta Sophia Files Third Party Submission

Patent application: salts of carboxylic acid-substituted tryptamines

View Press Release

December 3, 2025 | 3rd Party Submission

Enveric Biosciences Canada U.S. Patent Application 18/848,314 | Porta Sophia Files Third Party Submission

Patent application: carboxylic acid substituted tryptamines

View Press Release

December 2, 2025 | 3rd Party Submission

GH RESEARCH IRELAND LIMITED U.S. Patent Application 18/851,294 | Porta Sophia Files Third Party Submission

Patent application: 5-MeO-DMT for treatment of anxiety and comorbid psychiatric conditions

View Press Release

December 1, 2025 | Press Release

Monster Color Carnival LLC Relinquishes All Patent Rights in Response to Porta Sophia’s Inter Partes Review Challenging Patent on Psychedelic Administration via Vaporizer

Inter Partes Review Challenging Patent on Psychedelic Administration via Vaporizer

View Press Release
Learn about the status and impact of Porta Sophia's third party submissions and observations.

View Our Summary Chart